Jorge Hernando
Impact in
-
- Thyroid Cancer Diagnosis and Treatment
- Epidemiology top 5%
- Neuroendocrine Tumor Research Advances
Papers in
- Epidemiology 31
- Neuroendocrine Tumor Research Advances 31
-
- Thyroid Cancer Diagnosis and Treatment 15
- Co-authors
- Jaume Capdevila (37 shared papers)Paolo Giovanni Nuciforo (6 shared papers)Josep M. Tabernero (5 shared papers)Ana O. Hoff (3 shared papers)Marcia S. Brose (4 shared papers)Erika Hitre (2 shared papers)Jolanta Krajewska (2 shared papers)Daniel W. Bowles (2 shared papers)
- Journals
- Annals of Oncology (14 papers)The Oncologist (4 papers)Clinical & Translational Oncology (3 papers)Nature Communications (3 papers)European Journal of Cancer (3 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Jorge Hernando
56 papers receiving 1k citations
Jorge Hernando's Hit Papers
Peers
Comparison fields: 5 of 52
- Endocrinology, Diabetes and Metabolism 270
- Epidemiology 427
- Oncology 143
- Periodontics 37
- Biotechnology 15
Countries citing papers authored by Jorge Hernando
This map shows the geographic impact of Jorge Hernando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Hernando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Hernando more than expected).
Fields of papers citing papers by Jorge Hernando
This network shows the impact of papers produced by Jorge Hernando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Hernando. The network helps show where Jorge Hernando may publish in the future.
Co-authors
The 25 scholars most cited alongside Jorge Hernando, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2021 | 191 |
| 2 | 2020 | 129 | |
| 3 | 2021 | 82 | |
| 4 | 2023 | 54 | |
| 5 | 2018 | 53 | |
| 6 | 2023 | 46 | |
| 7 | 2023 | 41 | |
| 8 | 2019 | 35 | |
| 9 | 2020 | 34 | |
| 10 | 2022 | 34 | |
| 11 | 2021 | 28 | |
| 12 | 2022 | 25 | |
| 13 | 2018 | 20 | |
| 14 | 2021 | 19 | |
| 15 | 2022 | 18 | |
| 16 | 2024 | 18 | |
| 17 | 2022 | 13 | |
| 18 | 2023 | 13 | |
| 19 | 2019 | 11 | |
| 20 | 2023 | 11 |
About Jorge Hernando
Jorge Hernando is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism, Oncology, Surgery and Cancer Research, having authored 65 papers that have together received 1k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (31 papers), Thyroid Cancer Diagnosis and Treatment (15 papers), Adrenal and Paraganglionic Tumors (6 papers), Colorectal Cancer Surgical Treatments (3 papers), COVID-19 and healthcare impacts (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Renal cell carcinoma treatment (2 papers) and Oral microbiology and periodontitis research (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (270 citations), Epidemiology (427 citations), Oncology (143 citations), Periodontics (37 citations) and Biotechnology (15 citations). Jorge Hernando has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Jaume Capdevila, Paolo Giovanni Nuciforo, Josep M. Tabernero, Ana O. Hoff, Marcia S. Brose, Erika Hitre, Jolanta Krajewska, Daniel W. Bowles, Fernanda Vaisman and Steven I. Sherman. Their work appears in journals such as Annals of Oncology, The Oncologist, Clinical & Translational Oncology, Nature Communications and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.